VIVO Meridian Bioscience, Inc. Stock Quote

VIVO [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	21.51	EPS (ttm)	1.41	Insider Own	0.60%	Shs Outstand	43.55M	Perf Week	2.01%
Market Cap	1.32B	Forward P/E	28.70	EPS next Y	1.06	Insider Trans	-37.45%	Shs Float	42.89M	Perf Month	10.62%
Income	62.40M	PEG	1.27	EPS next Q	0.19	Inst Own	-	Short Float	5.83%	Perf Quarter	15.53%
Sales	339.30M	P/S	3.88	EPS this Y	51.70%	Inst Trans	4.26%	Short Ratio	6.29	Perf Half Y	52.25%
Book/sh	8.60	P/B	3.54	EPS next Y	-24.01%	ROA	13.70%	Target Price	30.00	Perf Year	37.15%
Cash/sh	1.77	P/C	17.22	EPS next 5Y	17.00%	ROE	18.20%	52W Range	17.04 - 31.93	Perf YTD	49.12%
Dividend	-	P/FCF	16.11	EPS past 5Y	16.40%	ROI	19.30%	52W High	-3.51%	Beta	0.28
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	10.10%	Gross Margin	58.80%	52W Low	80.81%	ATR	1.18
Employees	765	Current Ratio	3.90	Sales Q/Q	30.40%	Oper. Margin	23.70%	RSI (14)	62.41	Volatility	4.61% 4.02%
Optionable	Yes	Debt/Eq	0.07	EPS Q/Q	9.00%	Profit Margin	18.40%	Rel Volume	0.53	Prev Close	30.42
Shortable	Yes	LT Debt/Eq	0.07	Earnings	May 06 BMO	Payout	0.00%	Avg Volume	397.68K	Price	30.81
Recom	1.50	SMA20	7.58%	SMA50	14.14%	SMA200	33.61%	Volume	189,225	Change	1.28%

Aug-11-20

Resumed

Piper Sandler

Overweight

$24

Jul-27-20

Initiated

H.C. Wainwright

Buy

$34

May-11-20

Upgrade

William Blair

Mkt Perform → Outperform

May-01-19

Upgrade

Piper Jaffray

Underweight → Neutral

$15 → $11

Apr-03-19

Downgrade

Canaccord Genuity

Hold → Sell

$17 → $11

Jan-26-18

Reiterated

Canaccord Genuity

Hold

$14 → $16

Mar-28-17

Initiated

CL King

Neutral

Mar-28-16

Reiterated

Canaccord Genuity

Hold

$18 → $19

Sep-10-15

Reiterated

Canaccord Genuity

Hold

$19 → $18

Jul-27-15

Reiterated

Canaccord Genuity

Hold

$20 → $19

May-04-15

Reiterated

Canaccord Genuity

Hold

$19 → $20

Nov-06-14

Downgrade

Robert W. Baird

Outperform → Neutral

$22 → $22

Jul-27-12

Downgrade

Canaccord Genuity

Buy → Hold

Apr-25-11

Upgrade

Wedbush

Underperform → Neutral

$18 → $22

Mar-24-11

Upgrade

Canaccord Genuity

Hold → Buy

$30

Nov-16-10

Initiated

Canaccord Genuity

Hold

$21

Apr-07-10

Initiated

Wedbush

Underperform

$18

Nov-13-09

Reiterated

Caris & Company

Average

$21 → $20

Jul-07-09

Initiated

Caris & Company

Average

$21

Mar-06-09

Initiated

William Blair

Mkt Perform

Jul-01-22 09:29AM	Meridian Bioscience (NASDAQ:VIVO) Might Become A Compounding Machine Simply Wall St.
Jun-20-22 08:38AM	Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays PR Newswire
04:49AM	Meridian Bioscience (VIVO) Moves 5.7% Higher: Will This Strength Last? Zacks
Jun-16-22 09:02AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Meridian Bioscience, Inc.'s NASDAQ:VIVO) Stock? Simply Wall St.
May-27-22 12:14PM	One of Cincinnatis largest public companies will help develop monkeypox tests American City Business Journals +5.93%
May-26-22 01:31PM	Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests PR Newswire
May-23-22 01:13PM	Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference PR Newswire
May-17-22 03:33PM	Meridian Bioscience Launches Lyo-Ready Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays PR Newswire
07:47AM	We Think Meridian Bioscience (NASDAQ:VIVO) Can Stay On Top Of Its Debt Simply Wall St.
May-06-22 03:10PM	Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History Benzinga
09:15AM	Meridian Bioscience (VIVO) Q2 Earnings and Revenues Surpass Estimates Zacks
08:00AM	MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS PR Newswire
May-05-22 09:40AM	Has Computer Programs and Systems (CPSI) Outpaced Other Medical Stocks This Year? Zacks
09:12AM	Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names Zacks
09:00AM	Why Earnings Season Could Be Great for Meridian Bioscience (VIVO) Zacks
08:50AM	Meridian Bioscience (VIVO) is on the Move, Here's Why the Trend Could be Sustainable Zacks
May-03-22 10:47AM	What Awaits Meridian Bioscience (VIVO) This Earnings Season? Zacks
06:37AM	Cardinal Health (CAH) to Post Q3 Earnings: What's in Store? Zacks
06:35AM	AMN Healthcare (AMN) to Report Q1 Earnings: What's in Store? Zacks
May-02-22 10:01AM	DaVita (DVA) to Report Q1 Earnings: What's in the Offing? Zacks
08:47AM	Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities PR Newswire
08:25AM	DENTSPLY SIRONA (XRAY) to Post Q1 Earnings: What's in Store? Zacks
Apr-29-22 03:00PM	Meridian Bioscience (VIVO) Expected to Beat Earnings Estimates: Should You Buy? Zacks
12:10PM	Can Meridian Bioscience (VIVO) Keep the Earnings Surprise Streak Alive? Zacks
Apr-27-22 11:37AM	Boston Scientific (BSX) Q1 Earnings Top, 2022 Revenue View Up Zacks
11:01AM	Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase Zacks
10:25AM	Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up Zacks
09:05AM	Edwards Lifesciences (EW) Q1 Earnings Top Estimates, Margins Up Zacks
09:01AM	Henry Schein (HSIC) to Report Q1 Earnings: What's in Store? Zacks
Apr-26-22 12:34PM	Ecolab's (ECL) Q1 Earnings in Line, Revenues Beat Estimates Zacks -5.20%
11:48AM	Quidel (QDEL) to Report Q1 Earnings: What's in the Offing? Zacks
09:56AM	CVS Health (CVS) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-25-22 12:55PM	Catalent (CTLT) to Report Q3 Earnings: What's in the Cards? Zacks
08:38AM	Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store? Zacks
Apr-07-22 08:35AM	Meridian Bioscience Announces Preliminary Net Revenues Results for Fiscal 2022 Second Quarter PR Newswire +6.41%
08:06AM	Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group Zacks
Apr-06-22 08:50AM	What Makes Meridian Bioscience (VIVO) a Good Fit for "Trend Investing" Zacks
08:45AM	Bet on These 4 Low-Beta Stocks to Combat Market Volatility Zacks
Mar-31-22 07:57AM	VIVO Cannabis Announces Fourth Quarter 2021 Results Newsfile
Mar-29-22 02:37PM	Meridian Bioscience Launches Lyo-Ready qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection PR Newswire
Mar-25-22 07:43AM	New Strong Buy Stocks for March 25th Zacks
Mar-24-22 08:03AM	Zacks.com featured highlights include Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions Zacks
Mar-23-22 06:53AM	Buy These 4 Low-Beta Stocks to Combat the Choppy Market Zacks
Mar-21-22 07:49AM	Meridian Bioscience and NeuroPace have been highlighted as Zacks Bull and Bear of the Day Zacks
05:20AM	Bull of the Day: Meridian Bioscience (VIVO) Zacks
Mar-15-22 11:07AM	2 Top Stocks to Buy in March and Hold Forever Motley Fool
Mar-01-22 04:51PM	Royce Investment Partners Commentary- Market Opportunities: Two Premier Quality Small-Caps GuruFocus.com
Feb-21-22 09:00AM	Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer PR Newswire
Feb-16-22 09:05AM	Magellan Diagnostics Resumes Distribution of LeadCare® II Test Kits PR Newswire
Feb-10-22 11:50AM	Meridian Bioscience (NASDAQ:VIVO) stock performs better than its underlying earnings growth over last five years Simply Wall St.
Feb-08-22 12:20PM	Will Meridian Bioscience (VIVO) Gain on Rising Earnings Estimates? Zacks
Feb-04-22 11:30AM	Why Meridian Bioscience's Shares Are Rising Today? Benzinga +12.16%
09:15AM	Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates Zacks
08:00AM	MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY PR Newswire
Feb-01-22 01:38PM	Hgk Asset Management Inc Buys Fiserv Inc, Duke Energy Corp, Lockheed Martin Corp, Sells ... GuruFocus.com
Jan-31-22 11:45AM	Meridian Bioscience Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel PR Newswire
09:38AM	Hussman Strategic Advisors, inc Buys Pfizer Inc, Regeneron Pharmaceuticals Inc, Invesco, Sells ... GuruFocus.com
Jan-28-22 03:00PM	Earnings Preview: Meridian Bioscience (VIVO) Q1 Earnings Expected to Decline Zacks
10:05AM	Meridian Bioscience Launches Lyo-Ready qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection PR Newswire
06:23AM	Greater Cincinnati public company names new board chairman American City Business Journals
Jan-27-22 02:05PM	Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board PR Newswire
Jan-11-22 01:03PM	Why You Should Care About Meridian Bioscience's (NASDAQ:VIVO) Strong Returns On Capital Simply Wall St.
Jan-10-22 10:05AM	Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022 PR Newswire
Jan-05-22 10:15AM	Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay PR Newswire
Jan-04-22 02:00PM	Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference PR Newswire
Dec-22-21 09:59AM	High-ranking official at one of Cincinnati's largest public companies to retire American City Business Journals
Dec-07-21 11:38AM	Fuller & Thaler Behavioral Small Cap Equity Buys Exelixis Inc, ExlService Holdings Inc, LHC ... GuruFocus.com
Dec-02-21 08:00AM	Meridian Bioscience Announces Retirement of CFO Bryan Baldasare PR Newswire
Nov-24-21 09:05AM	Meridian Bioscience Announces Retirement of Chairman David Phillips PR Newswire
Nov-17-21 10:05AM	Meridian Launches Two New Air-Dryable Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing PR Newswire
Nov-12-21 01:30PM	Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript Motley Fool +7.19%
11:45AM	Meridian Bioscience's Q4 Earnings Beat Expectations Benzinga
07:30AM	Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance PR Newswire
Nov-10-21 08:55AM	Meridian Bioscience Receives FDA Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay PR Newswire
Nov-05-21 03:00PM	Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-27-21 10:05AM	Meridian Launches Innovative Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples PR Newswire
Oct-14-21 02:05PM	Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021 PR Newswire
Oct-07-21 02:00PM	Meridian Launches New Air-Dryable qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples PR Newswire
Oct-01-21 12:59PM	These 4 Measures Indicate That Meridian Bioscience (NASDAQ:VIVO) Is Using Debt Safely Simply Wall St.
Sep-09-21 10:00AM	Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples GlobeNewswire
Sep-07-21 10:00AM	Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples GlobeNewswire
Sep-02-21 07:58AM	Meridian Bioscience Expands Voluntary Recall of LeadCare Test Kits Benzinga
Sep-01-21 04:30PM	Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits ACCESSWIRE
Aug-30-21 02:00PM	Meridian Bioscience to Present at the H. C. Wainwright 23rd Annual Global Investment Conference ACCESSWIRE
Aug-27-21 10:15AM	Got $1,000? These 2 Bargain-Bin Biopharma Stocks Might Be Worth Buying Motley Fool
Aug-26-21 11:57AM	Those who invested in Meridian Bioscience (NASDAQ:VIVO) three years ago are up 28% Simply Wall St.
Aug-06-21 03:31PM	Meridian Bioscience Inc (VIVO) Q3 2021 Earnings Call Transcript Motley Fool
09:15AM	Meridian Bioscience (VIVO) Q3 Earnings and Revenues Miss Estimates Zacks
08:00AM	Meridian Bioscience Reports Third Quarter Fiscal 2021 Results GlobeNewswire
Aug-02-21 09:00AM	Meridian Closes Acquisition of BreathTek® Business GlobeNewswire
Jul-30-21 03:00PM	Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for Zacks
12:24PM	Hedge Funds Arent Crazy About Meridian Bioscience, Inc. (VIVO) Anymore Insider Monkey
Jul-23-21 10:39AM	Meridian To Buy Urea Breath Test For H. Pylori From Otsuka America Pharmaceutical For $20M Benzinga
09:20AM	Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc. GlobeNewswire
Jul-21-21 09:31AM	Investors Shouldn't Overlook The Favourable Returns On Capital At Meridian Bioscience (NASDAQ:VIVO) Simply Wall St.
Jul-14-21 09:00AM	Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021 GlobeNewswire
Jul-13-21 09:00AM	Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter GlobeNewswire -22.89%
Jul-09-21 05:45PM	Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-01-21 05:45PM	Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know Zacks
Jun-28-21 09:25AM	Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay GlobeNewswire

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kenny John P.	Chief Executive Officer	Jun 27	Option Exercise	10.10	61,437	620,514	326,568	Jun 28 09:42 AM
Kenny John P.	Chief Executive Officer	Jun 27	Sale	30.39	61,437	1,866,788	265,131	Jun 28 09:42 AM
Kenny John P.	Chief Executive Officer	Jun 24	Option Exercise	10.10	13,559	136,946	278,690	Jun 28 09:42 AM
Kenny John P.	Chief Executive Officer	Jun 24	Sale	30.00	13,559	406,836	265,131	Jun 28 09:42 AM
Kenny John P.	Chief Executive Officer	Jun 23	Option Exercise	11.28	19,956	225,091	285,087	Jun 24 12:33 PM
Kenny John P.	Chief Executive Officer	Jun 23	Sale	29.98	19,956	598,209	265,131	Jun 24 12:33 PM
Kenny John P.	Chief Executive Officer	Jun 22	Option Exercise	14.50	44,651	647,440	309,782	Jun 24 12:33 PM
Kenny John P.	Chief Executive Officer	Jun 22	Sale	29.72	44,651	1,326,921	265,131	Jun 24 12:33 PM
Kitzmiller Andrew S.	EVP & CFO	Feb 25	Buy	24.87	4,028	100,166	11,528	Feb 28 02:40 PM
WELTZIEN LOURDES	EVP, Life Science	Feb 15	Option Exercise	14.52	20,000	290,375	103,048	Feb 17 11:22 AM
WELTZIEN LOURDES	EVP, Life Science	Feb 15	Sale	25.60	20,000	511,912	83,048	Feb 17 11:22 AM
PHILLIPS DAVID	Director	Jan 12	Option Exercise	18.54	7,500	139,050	14,045	Jan 14 08:09 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience